Home › Funds › MPM BioImpact LLC › CORT
MPM BioImpact LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
MPM BioImpact LLC reported holding 771,028 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$67.0M, representing 4.09% of its reported portfolio and ranking #5 among its reported holdings. MPM BioImpact LLC has disclosed CORT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's CORT position evolved
MPM BioImpact LLC first disclosed a stake in CORT in Q1 2026 at 985,700 shares (US$39.7M). The position peaked in Q2 2026 at 771,028 shares, worth US$67.0M. Across 2 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 771,028 shares valued at US$67.0M — a reduction of -214,672 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 985.70K | $39.73M | New |
| Q2 2026 | 771.03K | $67.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$457.5M), Parallel Advisors, LLC (US$344.5M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M sh · $344.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K sh · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K sh · $40.42M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held CORT?
MPM BioImpact LLC has disclosed CORT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is MPM BioImpact LLC's current position in CORT?
As of Q2 2026, MPM BioImpact LLC holds 771.03K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $67.04M, representing 4.09% of its reported portfolio and ranking #5.
Has MPM BioImpact LLC been buying or selling CORT?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in CORT. The position peaked in Q2 2026 at 771.03K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.